RASA2 and cancer: This killing advantage after repetitive stimulation was specific, as demonstrated by the lack of cancer cell killing when either RASA2-KO or control TRAC CAR T cells were co-cultured with antigen-negative cancer cells (Extended Data Fig. 8f,g).